布地奈德雾化吸入对支原体感染诱发儿童哮喘的预防作用  

Preventive Effect of Aerosol Budesonide on Acute Asthma Caused by Mycoplasma Infection in Children

作　　者：施品英[1] 戚华[1] 沈鸣[1] 

机构地区：[1]江苏省南通市中医院儿科,226001

出　　处：《中华全科医学》2010年第3期315-316,共2页Chinese Journal of General Practice

摘　　要：目的观察布地奈德雾化吸入预防肺炎支原体感染诱发儿童哮喘急性发作的临床疗效。方法将122例既往符合支气管哮喘诊断标准,入院时尚未出现喘息的肺炎支原体感染患儿随机分成治疗组60例,对照组62例。治疗组在接受一般治疗的基础上,予布地奈德混悬液1mg加生理盐水至3ml雾化吸入,1次/d,疗程3～5d。结果治疗组出现喘息、肺部哮鸣音的比例明显低于对照组,其有效率明显优于对照组,差异有统计学意义(P<0.01)。结论布地奈德雾化吸入能有效减少肺炎支原体感染诱发的儿童哮喘急性发作。Objective To evaluate the preventive effect of aerosol budesonide on acute asthma caused by mycoplasma infection in children. Methods 122 previously asthmatic children with mycoplasma infection, on admission all children in asthmatic remission,they were randomly divided into two groups： treatment group（60 eases） and control group（62 cases）. Both group were treated by clinical routine therapy. Furthermore sixty cases of treatment group inhaled 1 mg budesonide every day for 3-5 days. Resuits The curative effect of treatment group was more obvious than that of control group （ P 〈 0.01 ）. Conclusion Aerosol budesonide may decrease acute asthma caused by mycoplasma infection in children.

关 键 词：布地奈德 支气管哮喘 肺炎支原体感染 预防 

分 类 号：R725.6[医药卫生—儿科] R977.1[医药卫生—临床医学]